Annual CFI
-$1.98 B
+$8.88 B+81.73%
31 December 2023
Summary:
GSK annual cash flow from investing activities is currently -$1.98 billion, with the most recent change of +$8.88 billion (+81.73%) on 31 December 2023. During the last 3 years, it has risen by +$460.00 million (+18.82%). GSK annual CFI is now -121.51% below its all-time high of $9.23 billion, reached on 31 December 2015.GSK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$926.64 M
-$1.90 B-195.28%
30 September 2024
Summary:
GSK quarterly cash flow from investing activities is currently -$926.64 million, with the most recent change of -$1.90 billion (-195.28%) on 30 September 2024. Over the past year, it has dropped by -$1.30 billion (-347.54%). GSK quarterly CFI is now -108.62% below its all-time high of $10.75 billion, reached on 31 March 2015.GSK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$231.21 M
-$284.89 M-55.20%
30 September 2024
Summary:
GSK TTM cash flow from investing activities is currently $231.21 million, with the most recent change of -$284.89 million (-55.20%) on 30 September 2024. Over the past year, it has increased by +$2.22 billion (+111.65%). GSK TTM CFI is now -97.57% below its all-time high of $9.52 billion, reached on 31 March 2015.GSK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -347.5% | +111.7% |
| 3 y3 years | +18.8% | -88.2% | +109.5% |
| 5 y5 years | +71.0% | -33.3% | +103.4% |
GSK Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +81.7% | -195.3% | +80.8% | -55.2% | +102.1% |
| 5 y | 5 years | -171.6% | +81.7% | -126.4% | +80.8% | -91.7% | +102.1% |
| alltime | all time | -121.5% | +81.7% | -108.6% | +82.0% | -97.6% | +102.1% |
GSK Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$926.64 M(-195.3%) | $231.21 M(-55.2%) |
| June 2024 | - | $972.50 M(-614.6%) | $516.10 M(-130.8%) |
| Mar 2024 | - | -$188.99 M(-150.5%) | -$1.68 B(-15.5%) |
| Dec 2023 | -$1.98 B(-81.7%) | $374.35 M(-158.3%) | -$1.98 B(-43.8%) |
| Sept 2023 | - | -$641.75 M(-47.5%) | -$3.53 B(-52.1%) |
| June 2023 | - | -$1.22 B(+146.3%) | -$7.38 B(+12.8%) |
| Mar 2023 | - | -$495.92 M(-57.8%) | -$6.54 B(-39.8%) |
| Dec 2022 | -$10.86 B(+344.3%) | -$1.17 B(-73.8%) | -$10.86 B(+6.7%) |
| Sept 2022 | - | -$4.49 B(+1076.0%) | -$10.18 B(+39.1%) |
| June 2022 | - | -$381.49 M(-92.1%) | -$7.32 B(+1.7%) |
| Mar 2022 | - | -$4.82 B(+879.1%) | -$7.20 B(+194.5%) |
| Dec 2021 | -$2.44 B(-188.1%) | -$492.34 M(-69.7%) | -$2.44 B(+19.9%) |
| Sept 2021 | - | -$1.63 B(+526.8%) | -$2.04 B(+105.7%) |
| June 2021 | - | -$259.51 M(+292.2%) | -$990.95 M(-135.6%) |
| Mar 2021 | - | -$66.17 M(-23.2%) | $2.78 B(+0.3%) |
| Dec 2020 | $2.77 B(-140.6%) | -$86.19 M(-85.1%) | $2.77 B(+28.1%) |
| Sept 2020 | - | -$579.08 M(-116.5%) | $2.16 B(-10.1%) |
| June 2020 | - | $3.51 B(-4825.8%) | $2.41 B(-236.6%) |
| Mar 2020 | - | -$74.34 M(-89.3%) | -$1.76 B(-74.2%) |
| Dec 2019 | -$6.84 B(+229.9%) | -$695.22 M(+106.2%) | -$6.84 B(+1.6%) |
| Sept 2019 | - | -$337.19 M(-48.6%) | -$6.73 B(-4.1%) |
| June 2019 | - | -$655.45 M(-87.3%) | -$7.01 B(+4.6%) |
| Mar 2019 | - | -$5.15 B(+776.9%) | -$6.70 B(+223.6%) |
| Dec 2018 | -$2.07 B(+11.2%) | -$587.09 M(-5.7%) | -$2.07 B(+9.2%) |
| Sept 2018 | - | -$622.40 M(+79.5%) | -$1.90 B(-0.1%) |
| June 2018 | - | -$346.72 M(-32.8%) | -$1.90 B(-10.9%) |
| Mar 2018 | - | -$515.88 M(+25.0%) | -$2.13 B(+14.5%) |
| Dec 2017 | -$1.86 B(+8.4%) | -$412.75 M(-33.9%) | -$1.86 B(+7.6%) |
| Sept 2017 | - | -$624.61 M(+7.8%) | -$1.73 B(+41.7%) |
| June 2017 | - | -$579.33 M(+135.1%) | -$1.22 B(+20.9%) |
| Mar 2017 | - | -$246.47 M(-12.3%) | -$1.01 B(-41.2%) |
| Dec 2016 | -$1.72 B(-118.6%) | -$281.06 M(+143.7%) | -$1.72 B(-22.7%) |
| Sept 2016 | - | -$115.35 M(-68.7%) | -$2.23 B(-1.5%) |
| June 2016 | - | -$368.14 M(-61.4%) | -$2.26 B(-8.8%) |
| Mar 2016 | - | -$954.82 M(+21.3%) | -$2.48 B(-126.8%) |
| Dec 2015 | $9.23 B(-619.2%) | -$787.36 M(+430.8%) | $9.23 B(-1.9%) |
| Sept 2015 | - | -$148.34 M(-74.7%) | $9.40 B(+2.2%) |
| June 2015 | - | -$585.19 M(-105.4%) | $9.20 B(-3.4%) |
| Mar 2015 | - | $10.75 B(-1862.0%) | $9.52 B(-635.9%) |
| Dec 2014 | -$1.78 B(-316.7%) | -$609.93 M(+72.2%) | -$1.78 B(-206.1%) |
| Sept 2014 | - | -$354.19 M(+36.1%) | $1.67 B(+39.3%) |
| June 2014 | - | -$260.20 M(-52.9%) | $1.20 B(+64.6%) |
| Mar 2014 | - | -$552.63 M(-119.4%) | $730.11 M(-10.9%) |
| Dec 2013 | $819.84 M(-119.7%) | $2.84 B(-443.6%) | $819.84 M(-133.7%) |
| Sept 2013 | - | -$827.03 M(+13.0%) | -$2.43 B(-55.0%) |
| June 2013 | - | -$732.11 M(+58.2%) | -$5.41 B(+11.3%) |
| Mar 2013 | - | -$462.90 M(+13.0%) | -$4.86 B(+16.5%) |
| Dec 2012 | -$4.17 B(+2221.4%) | -$409.51 M(-89.2%) | -$4.17 B(-7.5%) |
| Sept 2012 | - | -$3.80 B(+1972.7%) | -$4.51 B(+315.4%) |
| June 2012 | - | -$183.44 M(-181.1%) | -$1.08 B(-16.0%) |
| Mar 2012 | - | $226.19 M(-130.3%) | -$1.29 B(+618.9%) |
| Dec 2011 | -$179.59 M | -$746.38 M(+95.9%) | -$179.59 M(-35.3%) |
| Sept 2011 | - | -$381.08 M(-2.2%) | -$277.50 M(-59.5%) |
| June 2011 | - | -$389.75 M(-129.1%) | -$685.68 M(-33.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $1.34 B(-258.4%) | -$1.04 B(-64.0%) |
| Dec 2010 | -$2.88 B(-54.2%) | -$844.28 M(+7.0%) | -$2.88 B(-0.9%) |
| Sept 2010 | - | -$789.26 M(+6.5%) | -$2.91 B(-52.6%) |
| June 2010 | - | -$740.97 M(+46.7%) | -$6.13 B(+5.0%) |
| Mar 2010 | - | -$505.23 M(-41.9%) | -$5.83 B(-7.2%) |
| Dec 2009 | -$6.29 B(+195.8%) | -$869.75 M(-78.3%) | -$6.29 B(-8.1%) |
| Sept 2009 | - | -$4.01 B(+797.0%) | -$6.84 B(+110.6%) |
| June 2009 | - | -$447.25 M(-53.3%) | -$3.25 B(+25.5%) |
| Mar 2009 | - | -$957.18 M(-32.7%) | -$2.59 B(+21.8%) |
| Dec 2008 | -$2.12 B(-64.7%) | -$1.42 B(+237.4%) | -$2.12 B(-38.1%) |
| Sept 2008 | - | -$421.29 M(-298.3%) | -$3.43 B(-9.2%) |
| June 2008 | - | $212.41 M(-143.0%) | -$3.78 B(-18.7%) |
| Mar 2008 | - | -$494.38 M(-81.9%) | -$4.65 B(-22.8%) |
| Dec 2007 | -$6.03 B(+115.0%) | -$2.73 B(+255.3%) | -$6.03 B(+35.5%) |
| Sept 2007 | - | -$768.57 M(+16.6%) | -$4.45 B(-4.7%) |
| June 2007 | - | -$659.26 M(-64.7%) | -$4.67 B(+6.6%) |
| Mar 2007 | - | -$1.87 B(+62.3%) | -$4.38 B(+56.1%) |
| Dec 2006 | -$2.80 B(-7.2%) | -$1.15 B(+16.7%) | -$2.80 B(-54.2%) |
| Sept 2006 | - | -$986.11 M(+166.1%) | -$6.11 B(+81.6%) |
| June 2006 | - | -$370.62 M(+25.4%) | -$3.37 B(-2.9%) |
| Mar 2006 | - | -$295.50 M(-93.4%) | -$3.47 B(+14.9%) |
| Dec 2005 | -$3.02 B(+79.2%) | -$4.46 B(-353.4%) | -$3.02 B(-364.1%) |
| Sept 2005 | - | $1.76 B(-472.9%) | $1.14 B(-189.2%) |
| June 2005 | - | -$472.23 M(-408.3%) | -$1.28 B(+1.3%) |
| Mar 2005 | - | $153.16 M(-151.3%) | -$1.27 B(-24.9%) |
| Dec 2004 | -$1.69 B(+9.8%) | -$298.59 M(-55.1%) | -$1.69 B(-19.0%) |
| Sept 2004 | - | -$664.37 M(+45.6%) | -$2.08 B(+15.4%) |
| June 2004 | - | -$456.31 M(+71.3%) | -$1.80 B(+14.6%) |
| Mar 2004 | - | -$266.37 M(-61.6%) | -$1.57 B(+2.5%) |
| Dec 2003 | -$1.53 B(-6.1%) | -$692.91 M(+79.1%) | -$1.53 B(+2.5%) |
| Sept 2003 | - | -$386.79 M(+70.1%) | -$1.50 B(-1.9%) |
| June 2003 | - | -$227.36 M(-0.2%) | -$1.53 B(-5.7%) |
| Mar 2003 | - | -$227.83 M(-65.3%) | -$1.62 B(-1.0%) |
| Dec 2002 | -$1.64 B(-53.5%) | -$655.92 M(+57.6%) | -$1.64 B(-48.7%) |
| Sept 2002 | - | -$416.17 M(+30.4%) | -$3.19 B(-10.4%) |
| June 2002 | - | -$319.12 M(+30.8%) | -$3.55 B(+8.7%) |
| Mar 2002 | - | -$243.90 M(-89.0%) | -$3.27 B(-7.0%) |
| Dec 2001 | -$3.52 B(+379.3%) | -$2.21 B(+181.5%) | -$3.52 B(+72.2%) |
| Sept 2001 | - | -$784.33 M(+2223.2%) | -$2.04 B(+100.7%) |
| June 2001 | - | -$33.76 M(-93.1%) | -$1.02 B(-334.2%) |
| Mar 2001 | - | -$490.58 M(-33.1%) | $434.37 M(-159.2%) |
| Dec 2000 | -$733.60 M(-49.4%) | -$733.60 M(-405.1%) | -$733.60 M(<-9900.0%) |
| Sept 2000 | - | $240.46 M(-83.0%) | $0.00(-100.0%) |
| June 2000 | - | $1.42 B(-185.5%) | -$240.46 M(-85.5%) |
| Mar 2000 | - | -$1.66 B | -$1.66 B |
| Dec 1999 | -$1.45 B(+5.4%) | - | - |
| Dec 1998 | -$1.38 B(+27.8%) | - | - |
| Dec 1997 | -$1.08 B(+562.6%) | - | - |
| Dec 1996 | -$162.44 M(-97.9%) | - | - |
| Dec 1995 | -$7.57 B(+1.0%) | - | - |
| June 1995 | -$7.49 B(+267.0%) | - | - |
| June 1994 | -$2.04 B(+46.3%) | - | - |
| June 1993 | -$1.39 B(+113.1%) | - | - |
| June 1992 | -$654.38 M(-58.6%) | - | - |
| June 1991 | -$1.58 B | - | - |
FAQ
- What is GSK annual cash flow from investing activities?
- What is the all time high annual CFI for GSK?
- What is GSK quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for GSK?
- What is GSK quarterly CFI year-on-year change?
- What is GSK TTM cash flow from investing activities?
- What is the all time high TTM CFI for GSK?
- What is GSK TTM CFI year-on-year change?
What is GSK annual cash flow from investing activities?
The current annual CFI of GSK is -$1.98 B
What is the all time high annual CFI for GSK?
GSK all-time high annual cash flow from investing activities is $9.23 B
What is GSK quarterly cash flow from investing activities?
The current quarterly CFI of GSK is -$926.64 M
What is the all time high quarterly CFI for GSK?
GSK all-time high quarterly cash flow from investing activities is $10.75 B
What is GSK quarterly CFI year-on-year change?
Over the past year, GSK quarterly cash flow from investing activities has changed by -$1.30 B (-347.54%)
What is GSK TTM cash flow from investing activities?
The current TTM CFI of GSK is $231.21 M
What is the all time high TTM CFI for GSK?
GSK all-time high TTM cash flow from investing activities is $9.52 B
What is GSK TTM CFI year-on-year change?
Over the past year, GSK TTM cash flow from investing activities has changed by +$2.22 B (+111.65%)